Michael York
Plus aucun poste en cours
Fortune : 59 629 $ au 31/05/2023
Provenance du réseau au premier degré de Michael York
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 16 | |
| Public Company | Biotechnology | 16 | |
| Public Company | Pharmaceuticals: Major | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael York via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
Ulthera, Inc.
 Ulthera, Inc. Medical SpecialtiesHealth Technology Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC. | Medical Specialties | Director/Board Member Director/Board Member | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Founder Founder | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Investor Relations Contact Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| Claremont McKenna College | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
American Skin Association, Inc.
 American Skin Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Skin Association, Inc. engages in the development and research, education, prevention and treatment of skin disorders and cancers. It offers efforts to defeat melanoma, skin cancer and disease. The company was founded by George W. Hambrick on January 09, 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal President | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal Chairman | |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| GRITSTONE BIO, INC. | Biotechnology | Chairman Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ZURA BIO LIMITED | Biotechnology | President Human Resources Officer | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chairman | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 47 |
| Royaume-Uni | 2 |
| Suisse | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 12 |
| Finance | 4 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 283 |
| Independent Dir/Board Member | 98 |
| Corporate Officer/Principal | 95 |
| Chief Executive Officer | 54 |
| Founder | 44 |
Relations les plus connectées
| Insiders | |
|---|---|
| Amir Nashat | 49 |
| Eckard Weber | 46 |
| Kristina Burow | 40 |
| Richard Heyman | 33 |
| Peter Klein | 29 |
| William Humphries | 25 |
| Wendy Dixon | 25 |
| Deborah Jorn | 20 |
| Catherine C. Lee | 17 |
| Caroline Loewy | 17 |
| Jeffrey Jonker | 16 |
| Joseph Hagan | 15 |
| Tyrell J. Rivers | 15 |
| Preston Klassen | 15 |
| Linda Tufts | 14 |
- Bourse
- Insiders
- Michael York
- Connexions Sociétés
